» Articles » PMID: 37445409

Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia

Abstract

We performed a retrospective single-center analysis to investigate the diagnostic yield of bone marrow puncture in patients with liver cirrhosis and cytopenia. Liver cirrhosis patients receiving bone marrow aspiration or biopsy for the diagnostic work-up of otherwise unexplained peripheral blood cytopenia at our institution between 2004 and 2020 were enrolled in this study. We evaluated findings from cytologic, histologic and immunologic assessment and final diagnostic outcomes. A total of 118 patients with a median age of 55 years and a median Child-Pugh score of B (8 points) were enrolled. The main etiologies of liver cirrhosis were viral hepatitis (B and C) or chronic alcohol consumption. The majority of patients (60%) exhibited concurrent anemia, leukocytopenia and thrombocytopenia. Bone marrow assessment revealed normal, unspecific or reactive alterations in 117 out of 118 patients (99%). One patient was diagnosed with myelodysplastic syndrome. Our findings suggest that peripheral blood cytopenia in patients with liver cirrhosis is rarely associated with a primary bone marrow pathology.

Citing Articles

Hematological abnormalities in liver cirrhosis.

Fierro-Angulo O, Gonzalez-Regueiro J, Pereira-Garcia A, Ruiz-Margain A, Solis-Huerta F, Macias-Rodriguez R World J Hepatol. 2024; 16(9):1229-1244.

PMID: 39351511 PMC: 11438588. DOI: 10.4254/wjh.v16.i9.1229.

References
1.
Sheikh M, Raoufi R, Atla P, Riaz M, Oberer C, Moffett M . Prevalence of cirrhosis in patients with thrombocytopenia who receive bone marrow biopsy. Saudi J Gastroenterol. 2012; 18(4):257-62. PMC: 3409887. DOI: 10.4103/1319-3767.98431. View

2.
Berman L, AXELROD A . The blood and bone marrow in patients with cirrhosis of the liver. Blood. 1949; 4(5):511-33. View

3.
Kaushansky K . The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005; 115(12):3339-47. PMC: 1297257. DOI: 10.1172/JCI26674. View

4.
. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018; 69(1):154-181. DOI: 10.1016/j.jhep.2018.03.018. View

5.
Crabb D, Im G, Szabo G, Mellinger J, Lucey M . Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2019; 71(1):306-333. DOI: 10.1002/hep.30866. View